All information regarding prescription drugs on this site is intended only for doctors or pharmacists or nurses, authorized by local and national authorities to engage in their professions.

Kamada Ltd. is not responsible for any use made with this information, and use of it shall be the sole responsibility of the user.

KAMADA » PRODUCTS » IMMUNOGLOBULINS » MEGALOTECT

MEGALOTECT

Indications:

Prophylaxis of clinical manifestations of cytomegalovirus (CMV) infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.

Active Ingredient: CMV Immunoglobulin (Human)
Strength: 50 IU/ml
Volume: 10 ml, 20 ml, 50 ml
Method of Administration: Ready-to-use solution for intravenous injection

Join Our Mailing List

Latest News

Kamada announced the extension of an ongoing investigator initiated, proof-of-concept study evaluating the potential benefit of the Company’s liquid Alpha-1 Antitrypsin (AAT) on liver preservation and transplant rejection prevention.
Sep. 5, 2018